We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NMP:NASDAQNMP Acquisition Corp. Analysis

Data as of 2026-04-20 - not real-time

$10.17

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical indicators show the stock is perched at its 20‑day SMA (≈$10.15) and just touched the 30‑day resistance around $10.17, while the RSI is hovering near 69, signaling an overbought condition. MACD turned bullish but the histogram is barely positive, suggesting limited upside momentum. Volume remains extremely thin (single‑digit trades today versus a 10‑day average of ~1,680), creating a pronounced liquidity bottleneck despite a modest rise in the volume trend. On the fundamentals side, the company reports zero revenue, negative operating cash flow, and a price‑to‑book ratio above 200, indicating that the market price vastly exceeds any tangible asset base. The recent announcement of separate trading for Class A shares and rights adds a minor corporate‑action catalyst but does not address the core valuation mismatch. Overall, the stock appears overvalued with scant operational substance and heightened execution risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Price at technical resistance with overbought RSI
  • Extremely low trading volume and high liquidity risk
  • No operating revenue or earnings to justify price

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential catalyst if a merger or acquisition materializes
  • Current market sentiment (Extreme Greed) may sustain price temporarily
  • Continued absence of cash‑flow generation keeps downside risk elevated

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Fundamental disconnect between market cap and asset base
  • High price‑to‑book and price‑to‑earnings ratios with zero earnings
  • Sector‑wide scrutiny of SPACs reduces likelihood of value creation

Key Metrics & Analysis

Financial Health

P/E Ratio56.5
Debt/Equity0.63
P/B Ratio207.6
Op. Cash Flow$-542631
Industry P/E17.7

Technical Analysis

TrendBullish
RSI68.9
Support$10.13
Resistance$10.17
MA 20$10.15
MA 50$10.12
MA 200$10.04
MACDBullish
VolumeIncreasing
Fear & Greed Index86.95

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.00
Volatility1.78%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.